Gut Microbiota–Nanotechnology Interface: A New Frontier in Managing Obesity and Diabetes

Read full text Summarise with VIRAT
Authors: Winniefred Nankya
Cited by: 0
References: 42

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The gut microbiota plays a crucial role in maintaining metabolic homeostasis and influencing the development of obesity and type 2 diabetes (T2D). Dysbiosis, an imbalance in gut microbial composition, has been linked to insulin resistance, inflammation, and disrupted glucose metabolism. Recent advances in nanotechnology offer promising solutions to modulate the gut microbiota and its associated metabolic functions. Nanoparticles (NPs) can deliver therapeutic agents, regulate microbial composition, and enhance gut barrier function, all of which contribute to managing obesity and diabetes. This review explores the interface between gut microbiota and nanotechnology, highlighting the mechanisms through which nanoparticles influence microbial diversity, the therapeutic potential of nanomaterials in metabolic disease management, and the challenges and future directions for clinical application. Keywords: gut microbiota, nanotechnology, obesity, diabetes, metabolic disease

Fields of Study & Subjects

Gut microbiota and health Adipokines Inflammation and Metabolic Diseases Probiotics and Fermented Foods

Publication details

Journal / source
IAA Journal of Biological Sciences
Volume
14
Issue
1
Pages
82–86
Publication date
22 March 2026
Language
EN